Skip to main content

Delayed reversibility of complete atrioventricular block: cardio-biliary reflex after alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy

Abstract

Background

Complete atrioventricular block (AVB) is a life-threatening condition that usually occurs in elderly people with organic heart disease. We herein describe a rare case of complete AVB in a young man with hypertrophic obstructive cardiomyopathy (HOCM) complicated by cholecystitis and cholangitis. Both cardio-biliary reflex and alcohol septal ablation (ASA) can cause conduction block, but the latter is often irreversible. However, their simultaneous occurrence in a patient has not been reported.

Case presentation

A 31-year-old man presented with acute cholecystitis and cholangitis and complete AVB, which had been diagnosed at a local hospital on the third day after onset. On the fourth day, he was transferred to the emergency department of our hospital because of persistent complete AVB, although his abdominal pain had been partially relieved. An echocardiogram showed a remarkably elevated left ventricular outflow tract (LVOT) gradient (105.2 mmHg) despite the performance of ASA 9 years previously. The abdominal pain gradually disappeared, and normal sinus rhythm was completely recovered 11 days after onset. We determined that cardio-biliary reflex was the cause of the AVB because of the absence of other common causes. Finally, the patient underwent implantation of a permanent pacemaker to reduce the LVOT obstruction and avoid the risk of AVB recurrence.

Conclusions

Cholecystitis is a rare cause of complete AVB, which is a difficult differential diagnosis when complicated by HOCM after ASA. Clinicians should be alert to the possibility of cholecystitis in patients with abdominal pain and an unknown cause of bradycardia, complete AVB, or even sinus arrest.

Peer Review reports

Background

Complete atrioventricular block (AVB) is characterized as independent atrial and ventricular activity due to anatomic or functional disorders of the conduction system. Complete AVB may have physiologic, pathophysiologic, or iatrogenic etiologies, some of which are reversible [1]. Acute cholecystitis is a common surgical disease that is associated with arrhythmias or ST-T wave changes [2] through increased vagal tone. The latter, known as the cardio-biliary reflex, is self-restoring on an electrocardiogram (ECG) [3]. Alcohol septal ablation (ASA) was introduced in 1994 as an effective treatment option and an alternative to surgical myectomy for patients with hypertrophic obstructive cardiomyopathy (HOCM), helping to reduce left ventricular outflow tract obstruction (LVOTO) and associated symptoms. ASA-induced myocardial necrosis occurs in the basal septum, which closed to the cardiac conduction system and likely to cause conduction block [4].

This is the first report of 9 days of complete AVB complicated by biliary tract infection after ASA. In this mixed situation, a thorough clinical history and examination were important for accurate diagnosis and treatment.

Case presentation

A 31-year-old man presented with acute postprandial abdominal pain, vomiting, and progressive dyspnea until he was unable to walk on 5 January 2020 (Fig. 1). The patient was diagnosed with biliary tract infection and complete AVB (Fig. 2A) at a local hospital. Although his abdominal pain was partially relieved after anti-infective therapy, the complete AVB and dyspnea remained. He was transferred to the emergency department of our hospital on the fourth day after onset. He was afebrile with stable hemodynamics and showed no hypoxemia. He was able to lie supine without jugular vein distention and had rales with diminished breath sounds at both lung bases. A cardiac murmur was strongest at the left margin of the sternum between the third and fourth intercostal spaces; it was a grade III/VI total systolic murmur radiating to the periphery, armpit, and back. Tenderness was present in the upper abdomen with rebound pain and muscle tension, and Murphy’s sign was negative. The patient was diagnosed with HOCM in 2011 (Additional file 1: Figure S1). ASA was performed in 2011 because of recurrent syncope with a remarkably high left ventricular outflow tract (LVOT) gradient (125 mmHg) after the Valsalva maneuver. The patient was a deliveryman without restrictions for performing heavy manual labor after ASA. He denied taking any medications.

Fig. 1
figure1

Timeline of events. ASA alcohol septal ablation, HOCM hypertrophic obstructive cardiomyopathy, CB conduction block, AVB atrioventricular block, ED emergency department, HR heart rhythm

Fig. 2
figure2

Dynamic electrocardiogram changes on patient presentation. A Complete atrioventricular block (AVB) on the third day after onset in the local hospital. B Transferred to the emergency department of our hospital on the fifth day after onset. C Sinus rhythm partially passed down on eighth day after onset. D Complete right bundle branch block on 11th day after onset when AVB had disappeared

The patient was then sent to the cardiac care unit. Laboratory tests showed a white blood cell count of 10.01 × 109/L (reference range, 3.5–9.5 × 109/L), neutrophil percentage of 65.7%, alanine aminotransferase level of 257 IU/L (reference range, 9–50 IU/L), aspartate aminotransferase level of 110 IU/L (reference range, 15–40 IU/L), total bilirubin level of 54 µmol/L (reference range, 1.7–20 µmol/L), brain natriuretic peptide level of 2717 pg/mL (reference range, < 100 pg/mL), C-reactive protein level of 19 mg/L (reference range, < 5 mg/L), and procalcitonin level of 0.18 ng/mL (reference range, < 0.05 ng/mL). Serum electrolytes, troponin I, thyroid hormone, multiple blood cultures, antinuclear antibody, anti-dsDNA, complement C3/C4, rheumatoid factor, and anti-streptolysin O were all normal or negative. ECG showed complete AVB with junctional escape at 40 beats/min (Fig. 2B). Chest radiographs showed no lung lesions (Additional file 2: Figure S2). Abdominal computed tomography showed cholecystitis and cholangitis with peripheral exudation without stones (Fig. 3).

Fig. 3
figure3

Abdominal computed tomography. The gallbladder wall was edematous and thickened, and no gallstone was observed

Given the concern for heart failure and the previously auscultated cardiac murmur, the patient underwent echocardiographic examination. This showed mitral valve prolapse and a suspected mass, a left ventricular ejection fraction of 69.7%, and LVOTO with a gradient of 105.2 mmHg without change after the Valsalva maneuver (Fig. 4A, B). Subsequent transesophageal echocardiography revealed no valvular vegetation or mass (Fig. 4C). The patient underwent implantation of a temporary pacemaker on admission and was treated with meropenem, hepatoprotective drugs, and nutritional support.

Fig. 4
figure4

Echocardiogram. A Parasternal long-axis view on admission. B Doppler ultrasonic spectrum of LVOT on admission. C Transesophageal echocardiograph showed mitral valve prolapse and no vegetation. D Dynamic change of LVOT gradient and peak velocity. This patient underwent alcohol septal ablation on March 22, 2011 and permanent pacemaker on January 19, 2020. LVOT left ventricular outflow tract, ASA alcohol septal ablation, NM not measured, AVB atrioventricular block, TPM temporary pacemaker, PM pacemaker, PPM permanent pacemaker

The patient reported no abdominal pain when palpated on day 7 after onset. Unexpectedly, on day 8, we found that sinus rhythm could be partially passed down when attempting to reduce the pacing frequency (Fig. 2C). On the 11th day, the complete AVB disappeared, and the ECG showed complete right bundle branch block (Fig. 2D). During hospitalization, the peak velocity LVOT and LVOT gradient at rest and when provoked were monitored dynamically (Fig. 4D), and the results suggested that the LVOTO was still present even when normal rhythm was restored, either at rest or when provoked, and the pacemaker effectively reduced the LVOTO. Finally, the patient underwent permanent pacemaker implantation to reduce the LVOTO and prevent recurrence of AVB.

The patient was treated with a β-blocker and dual chamber pacing. After 18 months of follow-up, his New York Heart Association classification decreased from III to I without episodes of abnormal symptoms.

Discussion and conclusions

The causes of complete AVB are complex and various. We excluded myocardial infarction and myocarditis in this case because of the negative troponin I. Infective endocarditis could also be excluded because no valvular vegetations were present on transesophageal echocardiography. The lack of multisystem involvement made infiltrative cardiomyopathy an exception. Hyperkalemia, hyperthyroidism, and hypothyroidism could be easily ruled out based on the negative laboratory tests. In addition, AVB caused by progressive cardiac conduction system disease and cardiomyopathy are often irreversible.

The first differential diagnosis that we considered in this patient was a complication of the ASA procedure. Atrioventricular conduction disturbances following ASA are mainly seen in elderly patients, and pacemaker implantation is needed in only 5% of young patients [5, 6]. Patients with left bundle branch block, a P-R interval of > 200 ms, a greater pressure gradient during exercise before ablation, and advanced age are more likely to develop AVB after ASA [7, 8]. Complete AVB after ASA is usually seen within the first 24 h [9]. In one study, the incidence of late complete AVB was 8.9% more than 48 h after ASA and only 3.6% from 4 days to 3 years after ASA; no cases of complete AVB occurred after 3 years [8]. Late complete AVB may be explained by myocardial scarring and fibrosis after ASA [8, 10], and these changes are progressive and unlikely recoverable. Our patient had few risk factors for AVB, and no AVB was found within 48 h after ablation (Additional file 3: Figure S3). Complete AVB can aggravate LVOTO, which in turn leads to acute heart failure [11]. However, our patient had no typical symptoms of heart failure or episodes of syncope in daily life with heavy manual labor after ASA until the onset of acute biliary tract infection. Therefore, ASA was excluded as the cause of AVB, and the cardio-biliary reflex was determined to be the rare cause of the reversible AVB.

The cardio-biliary reflex is triggered by increased tension in the gallbladder via autonomic vagal innervations in patient with cholecystitis, regardless of the presence of pain or calculi [12, 13]. Bradycardia is one of the clinical presentations and is termed “Cope’s sign”; this phenomenon was first documented in 1971 by O'Reilly and Krauthamer [3]. The cardio-biliary reflex also mimics the special ECG changes of acute coronary syndrome, such as ST-segment elevation and T-wave inversion, which are identified and treated by atropine [2, 13, 14]. The cardio-biliary reflex is often a diagnosis of exclusion. Because of the lack of evidence of other diseases in this case, we speculated the cardio-biliary reflex was the predominant cause of the complete AVB. As shown in Table 1, only five such cases of conduction block have been reported, and the longest duration was about 48 h [12, 15,16,17,18]. Similar to the case reported by Lau et al. [12], our patient had persistent AVB despite disappearance of his abdominal pain, indicating that the inflammatory response may have resulted in prolonged activation of the cardio-biliary reflex although his inflammatory markers were slightly raised. Notably, complete right bundle branch block may have been involved in the unusually long duration of complete AVB, which was not mentioned in any previous cases.

Table 1 Review of case report on cardio-biliary reflex presented with bradycardia (not include arrhythmias during cholecystectomy)

According to the European Society of Cardiology guidelines on cardiac pacing and cardiac resynchronization therapy, permanent pacemaker implantation can be completely avoided if the conduction block is curable and self-recoverable [19]. Pacemaker therapy is not as effective as surgery or alcohol septal reduction in reducing the gradient; older patients are more likely to benefit from these procedures, and septal myectomy is recommended if mitral valve repair is required for treatment of mitral valve prolapse [11]. Our patient refused cholecystectomy and septal myectomy plus mitral valve prolapse repair surgery. After a multidisciplinary discussion, permanent pacemaker implantation was recommended based on the following three considerations: first, the cholecystitis may recur, which may cause recurrence of the AVB; second, a permanent pacemaker may reduce the LVOTO; and third, a pacemaker may provide security for the use of a β-blocker.

This case revealed a rare etiology and the longest duration (at least 9 days) of complete AVB complicated by acute biliary tract infection and HOCM after ASA. Cholecystitis causes multiple ECG abnormalities, and close monitoring and management are necessary to avoid misdiagnosis and possible complications. Further research is needed to elucidate the mechanism of the cardio-biliary reflex.

Availability of data and materials

Data are available from the corresponding author upon reasonable request.

Abbreviations

ASA:

Alcohol septal ablation

HOCM:

Hypertrophic obstructive cardiomyopathy

AVB:

Atrioventricular block

ECG:

Electrocardiogram

LVOT:

Left ventricular outflow tract

LVOTO:

Left ventricular outflow tract obstruction

References

  1. 1.

    Sodeck GH, Domanovits H, Meron G, Rauscha F, Losert H, Thalmann M, Vlcek M, Laggner AN. Compromising bradycardia: management in the emergency department. Resuscitation. 2007;73(1):96–102.

    CAS  Article  Google Scholar 

  2. 2.

    Kaufman JM, Lubera R. Preoperative use of atropine and electrocardiographic changes. Differentiation of ischemic from biliary-induced abnormalities. JAMA. 1967;200(3):197–200.

    CAS  Article  Google Scholar 

  3. 3.

    O’Reilly MV, Krauthamer MJ. “Cope’s sign” and reflex bradycardia in two patients with cholecystitis. Br Med J. 1971;2(5754):146.

    CAS  Article  Google Scholar 

  4. 4.

    Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer Z, Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, et al. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49(24):2356–63.

    Article  Google Scholar 

  5. 5.

    Leonardi RA, Townsend JC, Patel CA, Wolf BJ, Todoran TM, Powers ER, Steinberg DH, Fernandes VL, Nielsen CD. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients. Catheter Cardiovasc Interv. 2013;82(5):838–45.

    Article  Google Scholar 

  6. 6.

    Liebregts M, Steggerda RC, Vriesendorp PA, van Velzen H, Schinkel AF, Willems R, van Cleemput J, van den Berg MP, Michels M, ten Berg JM. Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly. JACC Cardiovasc Interv. 2016;9(5):463–9.

    Article  Google Scholar 

  7. 7.

    Axelsson A, Weibring K, Havndrup O, Kelbaek H, Jorgensen E, Helqvist S, Iversen K, Kober L, Bundgaard H, Jensen MK. Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2014;15(3):214–21.

    Article  Google Scholar 

  8. 8.

    Schuller JL, Zipse MM, Krantz MJ, Blaker B, Salcedo E, Groves BM, Messenger JC, Beaty B, Sauer WH. Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy. J Interv Cardiol. 2015;28(1):90–7.

    Article  Google Scholar 

  9. 9.

    Khouzam RN, Naidu SS. Current status and future perspectives on alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Curr Cardiol Rep. 2014;16(5):478.

    Article  Google Scholar 

  10. 10.

    Raute-Kreinsen U. Morphology of necrosis and repair after transcoronary ethanol ablation of septal hypertrophy. Pathol Res Pract. 2003;199(3):121–7.

    Article  Google Scholar 

  11. 11.

    Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733–79.

    Article  Google Scholar 

  12. 12.

    Lau YM, Hui WM, Lau CP. Asystole complicating acalculous cholecystitis, the “Cope’s sign” revisited. Int J Cardiol. 2015;182:447–8.

    Article  Google Scholar 

  13. 13.

    Krasna MJ, Flancbaum L. Electrocardiographic changes in cardiac patients with acute gallbladder disease. Am Surg. 1986;52(10):541–3.

    CAS  PubMed  Google Scholar 

  14. 14.

    Akyel A, Yayla C, Kunak T, Yaman B, Tavil Y, Boyaci B. Idioventricular rhythm in a patient with acute cholecystitis. Clin Res Hepatol Gastroenterol. 2011;35(11):774–6.

    Article  Google Scholar 

  15. 15.

    Papakonstantinou PE, Asimakopoulou NI, Kanoupakis E, Maragkoudakis S, Panagiotakis S, Gikas A. Cope’s sign and complete heart block in a 78-year-old patient with biliary colic. Int Emerg Nurs. 2018;37:3–5.

    Article  Google Scholar 

  16. 16.

    Franzen D, Jung S, Fatio R, Brunckhorst CB. Complete atrioventricular block in a patient with acute cholecystitis: a case of cardio-biliary reflex? Eur J Emerg Med. 2009;16(6):346–7.

    Article  Google Scholar 

  17. 17.

    Vloka ME, Tamis JE, Steinberg JS. Neurally mediated syncope in 2 patients with extracardiac disease. Arch Intern Med. 1999;159(6):625–7.

    CAS  Article  Google Scholar 

  18. 18.

    Ola RK, Sahu I, Ruhela M, Bhargava S. Cope’s sign: a lesson for novice physicians. J Family Med Primary Care. 2020;9(10):5375–7.

    Article  Google Scholar 

  19. 19.

    Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–329.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the patient and his family for granting their permission to publish this case report. The authors also thank Angela Morben, DVM, ELS, from Liwen Bianji (Edanz) (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.

Funding

None.

Author information

Affiliations

Authors

Contributions

FS, GL, and YF diagnosed and treated the patient. FS reviewed the literature and drafted the manuscript. GL and YF reviewed the literature. GYJ revised the manuscript for important intellectual content. All authors issued final approval for the version to be submitted. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yan-jun Gong.

Ethics declarations

Ethics approval and consent to participate

Not applicable. Study approval was not necessary because this is a case report, and consent for publication was obtained from the patient.

Consent for publication

Written informed consent was obtained from the patient for the publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1.

Cardiac magnetic resonance imaging.

Additional file 2: Figure S2.

Chest radiograph.

Additional file 3: Figure S3.

Electrocardiogram in 2011.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fang, S., Gao, L., Yang, F. et al. Delayed reversibility of complete atrioventricular block: cardio-biliary reflex after alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy. BMC Cardiovasc Disord 21, 372 (2021). https://doi.org/10.1186/s12872-021-02165-5

Download citation

Keywords

  • Cholecystitis
  • Cholangitis
  • Complete atrioventricular block
  • Cardio-biliary reflex
  • Alcohol septal ablation